A simple, sensitive, and universal platform for identification and quantification of trace-level protein impurities in biotherapeutics is described.
David Horn
Advertisement
David Horn is senior program manager at Thermo Fisher Scientific, San Jose, CA, USA.
Articles by David Horn
Advertisement
Latest Updated Articles
Identification and Quantification of Trace-Level Protein ImpuritiesPublished: September 1st 2013 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
3
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
4
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
5
